Rock Creek Pharmaceuticals, Inc. announced earnings results for the year ended December 31, 2015. For the year, the company reported a net loss from continuing operations of approximately $6.8 million compared to a net loss from continuing operations of approximately $33.1 million in 2014, a reduction in losses of $26.3 million. The reduction in the net loss was attributable to the reduced expenses as a result of the restructuring involving consolidation of offices, reduction in headcount, a reduction in non-cash share-based compensation and lower legal expenses.